Protein A Resin Market Set to Skyrocket to $1.2 Billion by 2022: Evolve Business Intelligence Study Unveils the Rise of Antibody Purification

As per the study initiated by Evolve Business Intelligence, the global Protein A Resin Market size accounted for USD 1.2 Billion in 2022, growing at a CAGR of 9.8% from 2023 to 2033. Protein A resin is a type of chromatography resin used for the purification of antibodies, particularly monoclonal antibodies. It is made from a porous matrix, typically made of agarose beads, that has been covalently linked to Protein A, a bacterial protein that specifically binds to the Fc region of immunoglobulin G (IgG) antibodies from many species, including humans, mice, and rabbits. The selective binding of the antibody to the Protein A resin allows for the separation and purification of the target protein from impurities in a mixture, such as other proteins or contaminants. Protein A resin is commonly used in the biopharmaceutical industry for the production of monoclonal antibodies for therapeutic use.
Request a Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=019130
Key Highlights:
• The global Protein A Resin Market size was valued at USD 1.2 billion in 2022 growing at a CAGR of 9.8% from 2023 to 2033.
• North America dominated the market in 2022
• Asia Pacific is expected to fastest-growing at the highest CAGR from 2023 to 2033
Evolve Business Intelligence has published a new market research report on the Global Protein A Resin Market focusing on various aspects including market size and forecast, market dynamics, competitors' market share analysis, market size in terms of value and volume, SWOT analysis, product benchmarking, key players recent developments, and opportunities, among others. The market has also been analyzed based on 4 indicators in the market dynamic chapter which include Drivers, Restraints, Key Trends, and Challenges. The overall sum of these sections will help to understand the best strategies to be adopted to prosper in this industry over the short and long terms. The quantitative analysis includes our authentic findings of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.
In terms of COVID-19 impact, the Protein A Resin Market report also includes the following data points:
• COVID-19 Impact on Protein A Resin Market Size
• End-User/Industry/Application Trend, and Preferences
• Government Policies/Regulatory Framework
• Key Players' Strategy to Tackle Negative Impact/Post-COVID Strategies
• Opportunity in Protein A Resin Market
Buy the Latest Copy of the Report Now at a Higher Discount: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=019130
Key Players
Some of the major Protein A Resin Market players holding high market share include GE Healthcare, Merck Millipore, PerkinElmer, Inc., and GenScript Biotech Corp. These players use partnership and collaboration as key strategy to gain significant market share to compete with market leaders.
The key players profiled in the report are:
• GE Healthcare
• Merck Millipore
• PerkinElmer, Inc.
• GenScript Biotech Corp.
• Agilent Technologies
• Repligen Corp.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Abcam PLC.
• Novasep Holdings SAS
Segmental Analysis
Market Segment ByType with focus on market share, consumption trend, and growth rate of Protein A Resin Market:
o Natural Protein A
o Recombinant Protein A
Market Segment ByProduct with focus on market share, consumption trend, and growth rate of Protein A Resin Market:
o Agarose-based Protein A
o Glass/Silica-based Protein A
o Organic Polymer-based Protein A
Market Segment ByApplication with focus on market share, consumption trend, and growth rate of Protein A Resin Market:
o Antibody Purification
o Immunoprecipitation
Market Segment By End User with Focus on market share, consumption trend, and growth rate of Protein A Resin Market:
o Pharmaceutical & Biopharmaceutical Companies
o Academic Research Institutes
Parameters Details
Market Size (2022) $ 1.2 Billion
CAGR (2023 to 2033) 9.8%
Market Segmentation Type, Product, Application, and End User
Country Covered US, Canada, Mexico, UK, Germany, France, Italy, Spain, Nordic Countries, BeNeLux, Rest of Europe, China, India, Japan, South Korea, Indonesia, Malaysia, Australia, Rest of Asia Pacific, Middle East & Africa, and South America
For more information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=019130
Global Protein A Resin Market Geographic Coverage:
• North America
o US
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Nordic Countries
o Benelux
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Australia
o Rest of Asia Pacific
• Middle East and Africa
o Saudi Arabia
o UAE
o Egypt
o South Africa
o Rest of MEA
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America
Reasons to Buy this Report:
• Detail analysis of the impact of market drivers, restraints, and opportunities
• Competitive Intelligence provides an understanding of the ecosystem
• Details analysis of the Total Addressable Market (TAM) of your products
• Investment Pockets and New Business Opportunities
• Demand-supply gap analysis
• Strategy Planning

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.